+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Surgical Anti-Adhesion Barrier Market - Global Forecast to 2030- Product Image
Surgical Anti-Adhesion Barrier Market - Global Forecast to 2030- Product Image
New

Surgical Anti-Adhesion Barrier Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6084987
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The surgical anti-adhesion barrier market addresses a critical need in modern operative care by mitigating the formation of postoperative adhesions that can lead to chronic pain, bowel obstruction and infertility. As surgical volumes rise globally, healthcare providers face mounting pressure to reduce complications and costs associated with adhesion-related readmissions. In response, manufacturers have developed a diverse array of barriers-ranging from film-based membranes to gel formulations and liquid solutions-engineered to separate tissue surfaces during healing. Technological breakthroughs in biomaterials, polymer chemistry and drug-eluting matrices have elevated product performance, safety and handling characteristics, enabling surgeons to tailor barrier selection to procedure type and patient profile. Meanwhile, evolving reimbursement frameworks and tighter regulatory scrutiny of biocompatibility and efficacy demand robust clinical evidence and quality controls. This report delivers a comprehensive overview of the market dynamics, profiles key players, and highlights emerging opportunities for differentiation. By synthesizing the latest innovations, regulatory shifts and competitive landscape, stakeholders will gain the insights needed to navigate a market poised for sustained growth and enhanced patient outcomes.

Transformative Shifts Redefining the Barrier Technology Landscape

The landscape of surgical anti-adhesion barriers is undergoing transformative shifts driven by interdisciplinary innovation and strategic realignment. Advanced biomaterials such as hydrogel sheets infused with novel cross-linking agents and drug-eluting polymers have entered clinical trials, challenging traditional film scaffolds. Concurrently, digital surgery platforms and artificial intelligence are being leveraged to optimize barrier placement and predict adhesion risk based on patient-specific data. Regulatory agencies are accelerating approvals for next-generation products that demonstrate improved adhesion prevention with minimal inflammatory response, prompting manufacturers to invest in robust safety and performance validation. In parallel, sustainability considerations are prompting a move toward bioresorbable materials derived from natural polymers, reducing environmental impact without compromising efficacy. Strategic partnerships between device makers, contract research organizations and academic centers are catalyzing rapid iteration and market entry. As the market evolves, competitive differentiation will hinge on the ability to integrate smart design, real-world evidence and eco-friendly manufacturing into cohesive product portfolios.

Cumulative Impact of United States Tariffs in 2025

United States tariff adjustments slated for 2025 are expected to have a cumulative impact on the supply chain for both synthetic and natural barrier materials. New duties on imported polyethylene glycol and water-soluble polymer gels may raise input costs for synthetic film-based barriers, while levies on chitosan derivatives and hyaluronic acid-based gels could translate into higher production expenses for natural gel formulations. Manufacturers relying on overseas raw material suppliers will need to reassess sourcing strategies to maintain price competitiveness. Some companies are already exploring the reshoring of key manufacturing processes and pursuing long-term direct agreements with domestic suppliers to mitigate tariff-induced margin pressures. Ultimately, these cost shifts may drive modest price adjustments in hospital and ambulatory surgical center contracts, influencing adoption rates. Meanwhile, the tariff environment underscores the importance of supply chain resilience and supply base diversification as strategic imperatives for sustaining growth in a tightening regulatory and economic climate.

Key Market Segmentation Insights

An in-depth segmentation analysis reveals distinct opportunities and performance drivers across five key dimensions. By product type, film-based barriers span biologically derived films-which include collagen-based and fibrin-based options-and synthetic films available as hydrogel sheets or polyethylene glycol membranes; gel-based barriers encompass natural gels such as chitosan derivatives and hyaluronic acid formulations as well as synthetic hydrogel formulations and water-soluble polymer gels; liquid solutions range from non-viscous options like neutral buffered saline and polyvinyl alcohol solutions to viscous agents based on cellulose and polyurethane. In terms of application, adhesion prevention spans general surgeries including abdominal procedures and intestinal resections, gynecological interventions such as hysterectomies and laparoscopic techniques, and orthopedic treatments covering joint replacements in hip and knee as well as spinal surgeries. Formulation insights highlight adhesion prevention systems employing cross-linking agents and gelation mechanisms alongside ready-to-use pre-filled syringes and spray bottles, as well as reconstituted powders and solution mixes. End-user segmentation differentiates between ambulatory surgical centers-both hospital controlled and independent-hospitals split into private and public institutions, and specialty clinics including gynecological and orthopedic practices. Finally, raw material trends contrast natural polymers such as agarose and chitosan with synthetic counterparts like polyethylene oxide and polyvinylpyrrolidone, each affecting barrier performance and cost structure.

Key Regional Market Dynamics and Growth Drivers

Regional dynamics shape adoption patterns and competitive intensity across three principal territories. In the Americas, broad reimbursement coverage in the United States and growing private healthcare investments in Canada and Brazil support strong uptake of premium barrier technologies, with clinical guidelines increasingly recommending adhesion prevention in high-risk procedures. Europe, Middle East & Africa present a heterogeneous market: Western European nations leverage centralized procurement and strict regulatory harmonization to drive quality-focused purchasing, whereas emerging economies in the Middle East and Africa show rising interest in cost-effective natural polymer barriers to manage healthcare budgets. In Asia-Pacific, expanding surgical volumes in China and India, coupled with aging populations in Japan and Australia, fuel robust demand; however, market entrants must navigate varying regulatory frameworks and local manufacturing requirements. Across all regions, strategic alliances with local distributors and tailored value propositions aligned to reimbursement systems will determine success in capturing growth potential.

Competitive Landscape: Leading Companies and Strategic Focuses

The competitive arena features a mix of global healthcare conglomerates, specialty device providers and innovative biotech firms. Allergan leverages its expertise in biologically derived film technologies to enhance collagen-based barrier portfolios, while Anika Therapeutics, Inc. advances its hyaluronic acid-based gels with targeted cross-linking chemistries. B. Braun Melsungen AG and Baxter International Inc. draw on broad surgical device networks to integrate film and gel formulations into comprehensive operative kits. Betatech Medical pioneers polyurethane-based liquid solutions designed for spinal surgery applications, whereas Biogennix, LLC. specializes in natural polymer scaffolds incorporating agarose and chitosan derivatives. CSL Behring focuses on fibrin-based films enhanced with plasma-derived proteins, and FzioMed, Inc. dedicates R&D resources to injectable water-soluble polymer gels with rapid gelation systems. Integra LifeSciences Corporation and its holding entity drive synergies between pre-filled spray systems and advanced cross-linking adhesion prevention systems. Johnson & Johnson (Ethicon Inc.) leverages its surgical portfolio to bundle synthetic hydrogel sheets with proprietary delivery devices. Lifeline Scientific, Inc. emphasizes reconstituted powder kits optimized for minimally invasive procedures, while Mast Biosurgery AG and Medtronic plc each pursue novel biodegradable matrices. Sanofi S.A. explores partnerships to incorporate drug-eluting agents, and Stryker Corporation integrates barrier solutions into its orthopedic product lines. Collectively, these companies are investing in next-generation materials, strategic collaborations and regional expansion to secure leadership positions.

Actionable Recommendations for Industry Leaders

Industry leaders can capitalize on evolving market dynamics by adopting a multi-pronged strategic framework. First, they should prioritize material innovation, channeling R&D toward bioresorbable and drug-eluting barrier platforms that demonstrate superior adhesion prevention and minimal inflammatory response. Second, executives must strengthen supply chain resilience by diversifying raw material sources, fostering domestic partnerships and exploring alternative polymer chemistries to offset geopolitical risks and tariff impacts. Third, forging strategic alliances with leading hospitals, ambulatory centers and specialty clinics will facilitate product adoption through co-development agreements and real-world evidence generation. Fourth, leveraging digital tools-such as AI-assisted risk stratification and surgical planning software-can differentiate offerings and drive physician engagement. Fifth, market access teams should tailor value propositions to region-specific reimbursement frameworks, emphasizing cost savings from reduced readmission rates and streamlined surgical workflows. Finally, sustainability initiatives in packaging and manufacturing will resonate with procurement officers and health systems seeking eco-conscious partners. By executing these actions in concert, organizations can secure competitive advantage and deliver improved patient outcomes.

Conclusion and Market Outlook

The surgical anti-adhesion barrier market stands at a pivotal juncture. Cutting-edge biomaterials and digital integration are redefining product capabilities, while regulatory and economic forces reshape competitive dynamics. Segmentation analysis underscores the need for targeted strategies across product types, applications, formulations, end-user settings and raw material choices. Regional insights reveal that success hinges on adapting to reimbursement environments and forging local partnerships. Leading companies are investing heavily in next-generation films, gels and liquid solutions, but sustained growth will depend on supply chain agility and evidence-driven value propositions. By embracing collaborative innovation, strategic sourcing and data-driven physician engagement, stakeholders can navigate the complexities of the market and capture emerging opportunities. The path forward combines technological advancement with operational excellence to reduce adhesion-related complications, optimize surgical workflows and enhance patient satisfaction.

Market Segmentation & Coverage

This research report categorizes the Surgical Anti-Adhesion Barrier Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Film-Based Barriers
    • Biologically Derived Film
      • Collagen-Based Films
      • Fibrin-Based Films
    • Synthetic Film
      • Hydrogel Sheets
      • Polyethylene Glycol
  • Gel-Based Barriers
    • Natural Gel
      • Chitosan Derivatives
      • Hyaluronic Acid-Based
    • Synthetic Gel
      • Hydrogel Formulations
      • Water-Soluble Polymer Gels
  • Liquid Solutions
    • Non-Viscous Solutions
      • Neutral Buffered Saline
      • Polyvinyl Alcohol Solutions
    • Viscous Solutions
      • Cellulose-Based Viscous Agents
      • Polyurethane Solutions
  • General Surgeries
    • Abdominal Surgeries
    • Intestinal Resection
  • Gynecological Surgeries
    • Hysterectomies
    • Laparoscopic Procedures
  • Orthopedic Surgeries
    • Joint Replacements
      • Hip Joint
      • Knee Joint
    • Spinal Surgeries
  • Adhesion Prevention Systems
    • Cross-Linking Agents
    • Gelation Systems
  • Ready-To-Use Formulations
    • Pre-Filled Syringes
    • Spray Bottles
  • Reconstituted Formulas
    • Powder Kits
    • Solution Mixes
  • Ambulatory Surgical Centers
    • Hospital Controlled
    • Independent Centers
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Specialty Clinics
    • Gynecological Clinics
    • Orthopedic Clinics
  • Natural Polymers
    • Agarose
    • Chitosan
  • Synthetic Polymers
    • Polyethylene Oxide
    • Polyvinylpyrrolidone

This research report categorizes the Surgical Anti-Adhesion Barrier Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Surgical Anti-Adhesion Barrier Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Allergan
  • Anika Therapeutics, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Betatech Medical
  • Biogennix, LLC.
  • CSL Behring
  • FzioMed, Inc.
  • Integra LifeSciences Corporation
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson (Ethicon Inc.)
  • Lifeline Scientific, Inc.
  • Mast Biosurgery AG
  • Medtronic plc
  • Sanofi S.A.
  • Stryker Corporation

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Surgical Anti-Adhesion Barrier Market, by Product Type
8.1. Introduction
8.2. Film-Based Barriers
8.2.1. Biologically Derived Film
8.2.1.1. Collagen-Based Films
8.2.1.2. Fibrin-Based Films
8.2.2. Synthetic Film
8.2.2.1. Hydrogel Sheets
8.2.2.2. Polyethylene Glycol
8.3. Gel-Based Barriers
8.3.1. Natural Gel
8.3.1.1. Chitosan Derivatives
8.3.1.2. Hyaluronic Acid-Based
8.3.2. Synthetic Gel
8.3.2.1. Hydrogel Formulations
8.3.2.2. Water-Soluble Polymer Gels
8.4. Liquid Solutions
8.4.1. Non-Viscous Solutions
8.4.1.1. Neutral Buffered Saline
8.4.1.2. Polyvinyl Alcohol Solutions
8.4.2. Viscous Solutions
8.4.2.1. Cellulose-Based Viscous Agents
8.4.2.2. Polyurethane Solutions
9. Surgical Anti-Adhesion Barrier Market, by Application
9.1. Introduction
9.2. General Surgeries
9.2.1. Abdominal Surgeries
9.2.2. Intestinal Resection
9.3. Gynecological Surgeries
9.3.1. Hysterectomies
9.3.2. Laparoscopic Procedures
9.4. Orthopedic Surgeries
9.4.1. Joint Replacements
9.4.1.1. Hip Joint
9.4.1.2. Knee Joint
9.4.2. Spinal Surgeries
10. Surgical Anti-Adhesion Barrier Market, by Formulation
10.1. Introduction
10.2. Adhesion Prevention Systems
10.2.1. Cross-Linking Agents
10.2.2. Gelation Systems
10.3. Ready-To-Use Formulations
10.3.1. Pre-Filled Syringes
10.3.2. Spray Bottles
10.4. Reconstituted Formulas
10.4.1. Powder Kits
10.4.2. Solution Mixes
11. Surgical Anti-Adhesion Barrier Market, by End-User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.2.1. Hospital Controlled
11.2.2. Independent Centers
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Specialty Clinics
11.4.1. Gynecological Clinics
11.4.2. Orthopedic Clinics
12. Surgical Anti-Adhesion Barrier Market, by Raw Material
12.1. Introduction
12.2. Natural Polymers
12.2.1. Agarose
12.2.2. Chitosan
12.3. Synthetic Polymers
12.3.1. Polyethylene Oxide
12.3.2. Polyvinylpyrrolidone
13. Americas Surgical Anti-Adhesion Barrier Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Surgical Anti-Adhesion Barrier Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Surgical Anti-Adhesion Barrier Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Allergan
16.3.2. Anika Therapeutics, Inc.
16.3.3. B. Braun Melsungen AG
16.3.4. Baxter International Inc.
16.3.5. Betatech Medical
16.3.6. Biogennix, LLC.
16.3.7. CSL Behring
16.3.8. FzioMed, Inc.
16.3.9. Integra LifeSciences Corporation
16.3.10. Integra LifeSciences Holdings Corporation
16.3.11. Johnson & Johnson (Ethicon Inc.)
16.3.12. Lifeline Scientific, Inc.
16.3.13. Mast Biosurgery AG
16.3.14. Medtronic plc
16.3.15. Sanofi S.A.
16.3.16. Stryker Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix

List of Figures
FIGURE 1. SURGICAL ANTI-ADHESION BARRIER MARKET MULTI-CURRENCY
FIGURE 2. SURGICAL ANTI-ADHESION BARRIER MARKET MULTI-LANGUAGE
FIGURE 3. SURGICAL ANTI-ADHESION BARRIER MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RAW MATERIAL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RAW MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SURGICAL ANTI-ADHESION BARRIER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SURGICAL ANTI-ADHESION BARRIER MARKET, FPNV POSITIONING MATRIX, 2024


List of Tables
TABLE 1. SURGICAL ANTI-ADHESION BARRIER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FILM-BASED BARRIERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY BIOLOGICALLY DERIVED FILM, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY COLLAGEN-BASED FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FIBRIN-BASED FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY BIOLOGICALLY DERIVED FILM, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC FILM, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HYDROGEL SHEETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY POLYETHYLENE GLYCOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC FILM, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FILM-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GEL-BASED BARRIERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY CHITOSAN DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HYALURONIC ACID-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL GEL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HYDROGEL FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY WATER-SOLUBLE POLYMER GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC GEL, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GEL-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY LIQUID SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NON-VISCOUS SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NEUTRAL BUFFERED SALINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY POLYVINYL ALCOHOL SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NON-VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY VISCOUS SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY CELLULOSE-BASED VISCOUS AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY POLYURETHANE SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ABDOMINAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY INTESTINAL RESECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HYSTERECTOMIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY LAPAROSCOPIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY JOINT REPLACEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HIP JOINT, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY KNEE JOINT, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY JOINT REPLACEMENTS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SPINAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ADHESION PREVENTION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY CROSS-LINKING AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GELATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ADHESION PREVENTION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY READY-TO-USE FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SPRAY BOTTLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY READY-TO-USE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RECONSTITUTED FORMULAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY POWDER KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SOLUTION MIXES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RECONSTITUTED FORMULAS, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HOSPITAL CONTROLLED, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY AGAROSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY POLYETHYLENE OXIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY POLYVINYLPYRROLIDONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FILM-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY BIOLOGICALLY DERIVED FILM, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC FILM, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GEL-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL GEL, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC GEL, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NON-VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY JOINT REPLACEMENTS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ADHESION PREVENTION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY READY-TO-USE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RECONSTITUTED FORMULAS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FILM-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY BIOLOGICALLY DERIVED FILM, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC FILM, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GEL-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL GEL, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC GEL, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NON-VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY JOINT REPLACEMENTS, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ADHESION PREVENTION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY READY-TO-USE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RECONSTITUTED FORMULAS, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FILM-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY BIOLOGICALLY DERIVED FILM, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC FILM, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GEL-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL GEL, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC GEL, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NON-VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY JOINT REPLACEMENTS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ADHESION PREVENTION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY READY-TO-USE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RECONSTITUTED FORMULAS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 167. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FILM-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 169. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY BIOLOGICALLY DERIVED FILM, 2018-2030 (USD MILLION)
TABLE 170. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC FILM, 2018-2030 (USD MILLION)
TABLE 171. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GEL-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 172. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL GEL, 2018-2030 (USD MILLION)
TABLE 173. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC GEL, 2018-2030 (USD MILLION)
TABLE 174. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 175. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NON-VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 176. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 177. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 179. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 180. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 181. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY JOINT REPLACEMENTS, 2018-2030 (USD MILLION)
TABLE 182. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 183. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ADHESION PREVENTION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 184. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY READY-TO-USE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 185. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RECONSTITUTED FORMULAS, 2018-2030 (USD MILLION)
TABLE 186. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 188. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 189. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 190. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 191. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
TABLE 192. CANADA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 193. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FILM-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 195. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY BIOLOGICALLY DERIVED FILM, 2018-2030 (USD MILLION)
TABLE 196. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC FILM, 2018-2030 (USD MILLION)
TABLE 197. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GEL-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 198. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL GEL, 2018-2030 (USD MILLION)
TABLE 199. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC GEL, 2018-2030 (USD MILLION)
TABLE 200. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 201. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NON-VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 202. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 203. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 205. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 206. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 207. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY JOINT REPLACEMENTS, 2018-2030 (USD MILLION)
TABLE 208. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 209. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ADHESION PREVENTION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 210. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY READY-TO-USE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 211. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RECONSTITUTED FORMULAS, 2018-2030 (USD MILLION)
TABLE 212. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 213. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 214. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 215. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 216. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 217. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
TABLE 218. MEXICO SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FILM-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY BIOLOGICALLY DERIVED FILM, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC FILM, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GEL-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL GEL, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC GEL, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NON-VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY JOINT REPLACEMENTS, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ADHESION PREVENTION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY READY-TO-USE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RECONSTITUTED FORMULAS, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 240. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 241. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 242. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 243. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
TABLE 244. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 245. UNITED STATES SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FILM-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY BIOLOGICALLY DERIVED FILM, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC FILM, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GEL-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL GEL, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC GEL, 2018-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NON-VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY JOINT REPLACEMENTS, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ADHESION PREVENTION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY READY-TO-USE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RECONSTITUTED FORMULAS, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL POLYMERS, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC POLYMERS, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FILM-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 275. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY BIOLOGICALLY DERIVED FILM, 2018-2030 (USD MILLION)
TABLE 276. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC FILM, 2018-2030 (USD MILLION)
TABLE 277. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GEL-BASED BARRIERS, 2018-2030 (USD MILLION)
TABLE 278. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NATURAL GEL, 2018-2030 (USD MILLION)
TABLE 279. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY SYNTHETIC GEL, 2018-2030 (USD MILLION)
TABLE 280. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY LIQUID SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 281. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY NON-VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 282. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY VISCOUS SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 283. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GENERAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 285. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY GYNECOLOGICAL SURGERIES, 2018-2030 (USD MILLION)
TABLE 286. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ORTHOPEDIC SURGERIES, 2018-2030 (USD MILLION)
TABLE 287. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY JOINT REPLACEMENTS, 2018-2030 (USD MILLION)
TABLE 288. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 289. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY ADHESION PREVENTION SYSTEMS, 2018-2030 (USD MILLION)
TABLE 290. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY READY-TO-USE FORMULATIONS, 2018-2030 (USD MILLION)
TABLE 291. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY RECONSTITUTED FORMULAS, 2018-2030 (USD MILLION)
TABLE 292. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 293. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA SURGICAL ANTI-ADHESION BARRIER MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLIO

Companies Mentioned

  • Allergan
  • Anika Therapeutics, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Betatech Medical
  • Biogennix, LLC.
  • CSL Behring
  • FzioMed, Inc.
  • Integra LifeSciences Corporation
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson (Ethicon Inc.)
  • Lifeline Scientific, Inc.
  • Mast Biosurgery AG
  • Medtronic plc
  • Sanofi S.A.
  • Stryker Corporation

Methodology

Loading
LOADING...

Related Topics

Related Reports

Anti-Adhesion Products Market by Product Type, Product Form, Application, End-User - Global Forecast 2025-2030 - Product Image

Anti-Adhesion Products Market by Product Type, Product Form, Application, End-User - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Anti-Adhesion Products - Global Strategic Business Report - Product Image

Anti-Adhesion Products - Global Strategic Business Report

  • Report
  • 183 Pages
  • Global
From
Europe Adhesion Barrier Market Size, Share & Industry Trends Analysis Report By Application Area, By Formulation, By Product, By End User, By Country and Growth Forecast, 2023 - 2030 - Product Image

Europe Adhesion Barrier Market Size, Share & Industry Trends Analysis Report By Application Area, By Formulation, By Product, By End User, By Country and Growth Forecast, 2023 - 2030

  • Report
  • 156 Pages
  • Europe
From
Adhesion Barriers - Global Strategic Business Report - Product Image

Adhesion Barriers - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Adhesion Barrier Market Size, Share & Trends Analysis Report By Product (Synthetic, Natural), By Formulation (Film/Mesh, Gel), By Application (Cardiovascular, Neurological Surgery), By Region And Segment Forecasts, 2023 - 2030 - Product Image

Adhesion Barrier Market Size, Share & Trends Analysis Report By Product (Synthetic, Natural), By Formulation (Film/Mesh, Gel), By Application (Cardiovascular, Neurological Surgery), By Region And Segment Forecasts, 2023 - 2030

  • Report
  • 140 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.